Literature DB >> 15844214

Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen-induced rat mammary tumors.

Stephen A Murray1, Shi Yang, Elizabeth Demicco, Haoqiang Ying, David H Sherr, Laurie J Hafer, Adrianne E Rogers, Gail E Sonenshein, Zhi-Xiong Jim Xiao.   

Abstract

It is thought that environmental pollutants, such as polycyclic aromatic hydrocarbons (PAH), contribute to human breast tumorigenesis, yet their roles remain incompletely elucidated. The prototypical PAH 7,12-dimethylbenz(alpha)anthracene (DMBA) specifically and effectively induces mammary tumor formation in rodent models. In an attempt to explore the molecular mechanisms by which PAH initiates and promotes mammary tumorigenesis, we examined the expression of several cell cycle regulators in rat mammary tumors induced by DMBA. Expression of cyclin D1, murine double minute-2 (MDM2), and Akt was up-regulated in tumors in comparison to normal mammary glands, as indicated by RT-PCR, Western blot analysis, and immunohistochemical staining. Expression of p27Kip1 protein was also elevated in the tumors with increased cytoplasmic localization. However, RB protein remained hyperphosphorylated. To directly test the effects of DMBA, the MCF-7 human breast cancer cells were treated. DMBA induced MDM2 expression in a dose- and time-dependent fashion in the MCF-7 cells, and this activation appeared to be p53 dependent. These data suggest that activation of cyclin D1, MDM2, and AKT as well as increased expression and cytoplasmic localization of p27Kip1 may play a role in this model of environmental pollutant-induced mammary tumorigenesis. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844214     DOI: 10.1002/jcb.20414

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

Review 2.  Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor.

Authors:  Mark E Hahn; Lenka L Allan; David H Sherr
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

Review 3.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

4.  Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression.

Authors:  Biswanath Maity; Adele Stewart; Yunxia O'Malley; Ryan W Askeland; Sonia L Sugg; Rory A Fisher
Journal:  Carcinogenesis       Date:  2013-04-18       Impact factor: 4.944

5.  The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.

Authors:  Elizabeth A Stanford; Zhongyan Wang; Olga Novikov; Francesca Mulas; Esther Landesman-Bollag; Stefano Monti; Brenden W Smith; David C Seldin; George J Murphy; David H Sherr
Journal:  BMC Biol       Date:  2016-03-16       Impact factor: 7.431

6.  2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway.

Authors:  Arijit Bhowmik; Nilanjana Das; Uttam Pal; Madhumita Mandal; Seemana Bhattacharya; Moumita Sarkar; Parasuraman Jaisankar; Nakul C Maiti; Mrinal K Ghosh
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

7.  Identification of genes differentially expressed between benign and osteopontin transformed rat mammary epithelial cells.

Authors:  Vittal V Kurisetty; Patrick G Johnston; Philip S Rudland; Mohamed K El-Tanani
Journal:  BMC Res Notes       Date:  2009-02-03

8.  EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in non‑small cell lung cancer cells.

Authors:  Chuan Lin; Yu Qin; Hua Zhang; Ming-Yang Gao; Yan-Fu Wang
Journal:  Oncol Rep       Date:  2018-05-08       Impact factor: 3.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.